A detailed history of Colony Group LLC transactions in Cerus Corp stock. As of the latest transaction made, Colony Group LLC holds 93,200 shares of CERS stock, worth $154,712. This represents 0.0% of its overall portfolio holdings.

Number of Shares
93,200
Previous 93,200 -0.0%
Holding current value
$154,712
Previous $229,000 34.06%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$3.38 - $4.22 $6,760 - $8,440
2,000 Added 2.19%
93,200 $340,000
Q3 2021

Nov 17, 2021

BUY
$4.79 - $6.68 $436,848 - $609,216
91,200 New
91,200 $555,000
Q2 2021

Aug 18, 2021

SELL
$5.35 - $6.35 $477,219 - $566,420
-89,200 Closed
0 $0
Q2 2019

Aug 19, 2019

BUY
$4.51 - $6.6 $402,292 - $588,720
89,200 New
89,200 $501,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $294M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Colony Group LLC Portfolio

Follow Colony Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.